Review of phenobarbitone use for deep terminal sedation in a UK hospice

Abstract

Get full access to this article

View all access options for this article.

References

Rietjens JAC , Buiting HM , Pasman HRW , van der Maas PJ , van Delden JJM , van der Heide A. Deciding about continuous deep sedation: physicans’ perspectives. Palliat Med 2009; 23: 410-417.

Stirling C. , Kurowska A. , Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage 1999; 17: 363-368.

van der Heide A. , Onwuteaka-Philipsen BD , Rurup ML , et al. End-of-life practices in the Netherlands under the Euthanasia Act. N Eng J Med 2007; 356: 1957-1965.

Twycross R. Use of phenobarbitone, The palliative care formulary. 3rd edn. Palliativebooks.com, 2007, pp. 204-207.